Baxter International Inc. (BAX): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Baxter International ( BAX) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day up 0.7%. By the end of trading, Baxter International fell $0.81 (-1.1%) to $72.81 on average volume. Throughout the day, 2,644,831 shares of Baxter International exchanged hands as compared to its average daily volume of 3,295,600 shares. The stock ranged in price between $72.63-$73.58 after having opened the day at $73.40 as compared to the previous trading day's close of $73.62. Other companies within the Health Services industry that declined today were: Pingtan Marine Enterprise ( PME), down 6.4%, NeuroMetrix ( NURO), down 5.8%, Cryolife ( CRY), down 5.4% and Sunshine Heart ( SSH), down 4.6%.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $40.3 billion and is part of the health care sector. Shares are up 11.4% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Boston Scientific ( BSX), up 12.7%, IsoRay ( ISR), up 12.6%, Invacare Corporation ( IVC), up 7.4% and Ironwood Pharmaceuticals ( IRWD), up 7.4% , were all gainers within the health services industry with Catamaran ( CTRX) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round

Buy These High-Octane Stocks on a Dip: Cramer's 'Mad Money' Recap (Monday 8/7/17)

These Stocks Are Ready to Reverse Course

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways